Giant cell tumor of tendon sheath in the hand: analysis of risk factors for recurrence in 50 cases

by Hakan Ozben, Tamer Coskun
Published 2019-10-01

The osteoid osteoma of the proximal phalanx; diagnosis and treatment

by Tamer Coskun, Hasan Onur Arik, A.Gursel Leblebicioglu
Published 2018-08-01

FGF21 requires βklotho to act in vivo.

by Andrew C Adams, Christine C Cheng, Tamer Coskun, Alexei Kharitonenkov
Published 2012-01-01

A simplified procedure to trace triglyceride‐rich lipoprotein metabolism in vivo

by Zhixiong Ying, Mariëtte R. Boon, Tamer Coskun, Sander Kooijman, Patrick C. N. Rensen
Published 2021-04-01

Treatment results in isolated humerus majus fractures

by Hakan Serhat Yanık, Mehmet Kerem Canbora, Atilla Polat, Tamer Coşkun, Hasan Bombacı, Şevki Erdem, Abdullah Demirtaş
Published 2012-09-01

Glucose dysregulation and response to common anti-diabetic agents in the FATZO/Pco mouse.

by Richard G Peterson, Charles Van Jackson, Karen M Zimmerman, Jorge Alsina-Fernandez, M Dodson Michael, Paul J Emmerson, Tamer Coskun
Published 2017-01-01

Correlation of disease severity with body weight and high fat diet in the FATZO/Pco mouse.

by Brian A Droz, Bria L Sneed, Charles V Jackson, Karen M Zimmerman, M Dodson Michael, Paul J Emmerson, Tamer Coskun, Richard G Peterson
Published 2017-01-01

Correction: A Novel Humanized GLP-1 Receptor Model Enables Both Affinity Purification and Cre-LoxP Deletion of the Receptor.

by Lucy S Jun, Aaron D Showalter, Nosher Ali, Feihan Dai, Wenzhen Ma, Tamer Coskun, James V Ficorilli, Michael B Wheeler, M Dodson Michael, Kyle W Sloop
Published 2015-01-01

A novel humanized GLP-1 receptor model enables both affinity purification and Cre-LoxP deletion of the receptor.

by Lucy S Jun, Aaron D Showalter, Nosher Ali, Feihan Dai, Wenzhen Ma, Tamer Coskun, James V Ficorilli, Michael B Wheeler, M Dodson Michael, Kyle W Sloop
Published 2014-01-01

Fundamentals of FGF19 & FGF21 action in vitro and in vivo.

by Andrew C Adams, Tamer Coskun, Armando R Irizarry Rovira, Michael A Schneider, David W Raches, Radmila Micanovic, Holly A Bina, James D Dunbar, Alexei Kharitonenkov
Published 2012-01-01

Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice

by Robin van Eenige, Zhixiong Ying, Lauren Tambyrajah, Amanda C.M. Pronk, Niek Blomberg, Martin Giera, Yanan Wang, Tamer Coskun, Mario van der Stelt, Patrick C.N. Rensen, Sander Kooijman
Published 2021-01-01

Novel Small Molecule Agonist of TGR5 Possesses Anti-Diabetic Effects but Causes Gallbladder Filling in Mice.

by Daniel A Briere, Xiaoping Ruan, Christine C Cheng, Angela M Siesky, Thomas E Fitch, Carmen Dominguez, Sonia Gutierrez Sanfeliciano, Carlos Montero, Chen S Suen, Yanping Xu, Tamer Coskun, M Dodson Michael
Published 2015-01-01

The anti-obesity effect of FGF19 does not require UCP1-dependent thermogenesis

by Patrick J. Antonellis, Brian A. Droz, Richard Cosgrove, Libbey S. O'Farrell, Tamer Coskun, James W. Perfield, II, Steven Bauer, Mark Wade, Tara E. Chouinard, Joseph T. Brozinick, Andrew C. Adams, Ricardo J. Samms
Published 2019-12-01

Whole-body and adipose tissue-specific mechanisms underlying the metabolic effects of fibroblast growth factor 21 in the Siberian hamster

by Jo E. Lewis, Chloe Monnier, Hayley Marshall, Maxine Fowler, Rebecca Green, Scott Cooper, Aristeidis Chiotellis, Jeni Luckett, Alan C. Perkins, Tamer Coskun, Andrew C. Adams, Ricardo J. Samms, Francis J.P. Ebling, Kostas Tsintzas
Published 2020-01-01

Rational design of a fibroblast growth factor 21-based clinical candidate, LY2405319.

by Alexei Kharitonenkov, John M Beals, Radmila Micanovic, Beth A Strifler, Radhakrishnan Rathnachalam, Victor J Wroblewski, Shun Li, Anja Koester, Amy M Ford, Tamer Coskun, James D Dunbar, Christine C Cheng, Christopher C Frye, Thomas F Bumol, David E Moller
Published 2013-01-01

The cytokine GDF15 signals through a population of brainstem cholecystokinin neurons to mediate anorectic signalling

by Amy A Worth, Rosemary Shoop, Katie Tye, Claire H Feetham, Giuseppe D'Agostino, Garron T Dodd, Frank Reimann, Fiona M Gribble, Emily C Beebe, James D Dunbar, Jesline T Alexander-Chacko, Dana K Sindelar, Tamer Coskun, Paul J Emmerson, Simon M Luckman
Published 2020-07-01

LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept

by Tamer Coskun, Kyle W. Sloop, Corina Loghin, Jorge Alsina-Fernandez, Shweta Urva, Krister B. Bokvist, Xuewei Cui, Daniel A. Briere, Over Cabrera, William C. Roell, Uma Kuchibhotla, Julie S. Moyers, Charles T. Benson, Ruth E. Gimeno, David A. D'Alessio, Axel Haupt
Published 2018-12-01

The GPR120 agonist TUG‐891 promotes metabolic health by stimulating mitochondrial respiration in brown fat

by Maaike Schilperoort, Andrea D vanDam, Geerte Hoeke, Irina G Shabalina, Anthony Okolo, Aylin C Hanyaloglu, Lea H Dib, Isabel M Mol, Natarin Caengprasath, Yi‐Wah Chan, Sami Damak, Anne Reifel Miller, Tamer Coskun, Bharat Shimpukade, Trond Ulven, Sander Kooijman, Patrick CN Rensen, Mark Christian
Published 2018-03-01

High Fat Diet Increases Circulating Endocannabinoids Accompanied by Increased Synthesis Enzymes in Adipose Tissue

by Eline N. Kuipers, Eline N. Kuipers, Vasudev Kantae, Boukje C. Eveleens Maarse, Boukje C. Eveleens Maarse, Susan M. van den Berg, Robin van Eenige, Robin van Eenige, Kimberly J. Nahon, Kimberly J. Nahon, Anne Reifel-Miller, Tamer Coskun, Menno P. J. de Winther, Esther Lutgens, Esther Lutgens, Sander Kooijman, Sander Kooijman, Sander Kooijman, Amy C. Harms, Thomas Hankemeier, Mario van der Stelt, Patrick C. N. Rensen, Patrick C. N. Rensen, Mariëtte R. Boon, Mariëtte R. Boon
Published 2019-01-01